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Abstract
Natural killer (NK) cells have different roles in the host response against Plasmodium-induced malaria depending on the
stage of infection. Liver NK cells have a protective role during the initial hepatic stage of infection by production of the TH1-
type cytokines IFN-c and TNF-a. In the subsequent erythrocytic stage of infection, NK cells also induce protection through
Th1-type cytokines but, in addition, may also promote development of cerebral malaria via CXCR3-induction on CD8+ T cells
resulting in migration of these cells to the brain. We have recently shown that the regulatory Ly49E NK receptor is expressed
on liver NK cells in particular. The main objective of this study was therefore to examine the role of Ly49E expression in the
immune response upon Plasmodium berghei ANKA infection, for which we compared wild type (WT) to Ly49E knockout (KO)
mice. We show that the parasitemia was higher at the early stage, i.e. at days 6–7 of Plasmodium berghei ANKA infection in
Ly49E KO mice, which correlated with lower induction of CD69, IFN-c and TNF-a in DX52 liver NK cells at day 5 post-
infection. At later stages, these differences faded. There was also no difference in the kinetics and the percentage of cerebral
malaria development and in lymphocyte CXCR3 expression in WT versus Ly49E KO mice. Collectively, we show that the
immune response against Plasmodium berghei ANKA infection is not drastically affected in Ly49E KO mice. Although NK cells
play a crucial role in Plasmodium infection and Ly49E is highly expressed on liver NK cells, the Ly49E NK receptor only has a
temporarily role in the immune control of this parasite.
Citation: Filtjens J, Foquet L, Taveirne S, Van Ammel E, Vanhees M, et al. (2014) Contribution of the Ly49E Natural Killer Receptor in the Immune Response to
Plasmodium berghei Infection and Control of Hepatic Parasite Development. PLoS ONE 9(1): e87463. doi:10.1371/journal.pone.0087463
Editor: Laurent Re´nia, Agency for Science, Technology and Research - Singapore Immunology Network, Singapore
Received August 30, 2013; Accepted December 28, 2013; Published January 30, 2014
Copyright:  2014 Filtjens et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Foundation against Cancer, a foundation of public interest, and by the Fund for Scientific Research Flanders (FWO).
J.F., L.F., M.V. and A.V.A. are supported by the Institute for the Promotion of Innovation through Science and Technology Flanders (IWT-Vlaanderen), S.T. is
supported by the BOF Ghent University, T.K. and T.T. are supported by the FWO. P.E.V.d.S. holds a Research Professorship of the KU Leuven. The funders had no
role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: georges.leclercq@ugent.be
Introduction
Malaria is a global disease that resulted in more than 650,000
deaths in 2010 (www.who.int). It is caused by protozoan
Plasmodium parasites that are transmitted by infected Anopheles
mosquitoes. The Plasmodium sporozoites enter the body and invade
dermal blood vessels to reach the bloodstream, after which they
migrate to the liver, initiating the hepatic stage of the infection.
Sporozoites invade hepatocytes and develop into mature liver
schizonts, each containing multiple merozoites. After schizont
rupture, merozoites invade red blood cells (RBCs) leading to the
symptomatic phase of infection, also called the erythrocytic stage.
Here, a cyclic phase starts in which merozoites develop in the
RBC as ring forms, followed by the progression to trophozoites
and eventually to mature schizonts. Rupture of these schizonts and
lysis of the RBCs results in release of a new wave of merozoites,
which invade other RBCs [1–3].
Roland et al. [4] showed that hepatic and splenic natural killer
(NK) cells are activated during the early phase of infection with
Plasmodium yoelii sporozoites. This results in an increase in the
number of liver NK cells and in production of the TH1-type
cytokines IFN-c and TNF-a by splenic and hepatic NK cells. Liver
NK cells are cytotoxic against the Plasmodium liver stages, but not
against the Plasmodium erythrocytic stages. These in vitro data
indicating a protective role of NK cells were confirmed by in vivo
experiments, showing that NK cells are particularly involved in the
early immune response controlling the hepatic phase of Plasmodium
infection [4]. In the erythrocytic phase, NK cells also contribute to
the control of parasitemia by producing Th1 cytokines, which
further potentiate e.g. phagocytosis by macrophages [5;6]. Finally,
NK cells have been shown to promote development of murine
cerebral malaria, as NK cell depletion results in inhibition of T cell
recruitment to the brain of Plasmodium berghei-infected animals,
which correlates with the down-regulation of the chemokine
receptor CXCR3 [7].
NK cells display a broad repertoire of activating and inhibitory
cell surface receptors, which regulate NK cell activity. In mice,
inhibitory NK receptors, including members of the Ly49 receptor
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family and the CD94/NKG2A receptor, bind major histocom-
patibility complex (MHC) class-I and MHC class I-like molecules.
Signaling by these receptors occurs via cytoplasmic immunor-
eceptor tyrosine-based inhibitory motifs. Activating receptors, on
the contrary, possess a charged transmembrane residue and couple
to the immunoreceptor tyrosine-based activating motif-bearing
adaptor molecules DAP12, CD3f or FceRc [8–10]. NK cell
activation occurs when MHC class-I molecules on transformed or
infected cells are absent, eliminating the inhibitory signal
(‘‘missing-self recognition’’), or when ligands for activating NK
receptors are upregulated (‘‘induced-self recognition’’) [11–15].
Ly49E is a unique member of the murine Ly49 NK receptor
family that displays characteristics that clearly distinguish this
receptor from other Ly49 family members. Unlike other NK
receptors, Ly49E fails to bind classical MHC class-I ligands [16].
Instead, we showed that this receptor is triggered by urokinase
plasminogen activator (uPA), a non-MHC class-I molecule [17].
Also, Ly49E is the only Ly49 receptor expressed on fetal and
neonatal NK cells [18;19]. In contrast, in adult tissues Ly49E
expression is restricted to skin Vc3 T cells [20;21] and intestinal
intraepithelial T lymphocytes [22;23]. Ly49E is largely absent on
conventional peripheral NK cells in adult mice [19;20;24].
However, DX5- liver NK cells express high levels of Ly49E, and
this both in fetal, newborn and adult mice [25].
As NK cells play a crucial role in the immune response
controlling Plasmodium infection [4–6], and as we have recently
shown that murine liver NK cells express high levels of the Ly49E
receptor [25], we hypothesized that Ly49E plays a regulatory role
in the NK response during this infection. As we have recently
generated an Ly49E knockout (KO) mouse [25], we now have an
ideal model to study this hypothesis. We here examined the
immune response, parasitemia, cerebral malaria and survival of
Ly49E KO vs wild type (WT) mice upon infection with Plasmodium
berghei sporozoites.
Materials and Methods
Mice and Plasmodium berghei infection
WT and Ly49E KO mice (C57BL/6 background) were bred
and housed in our SPF animal facility in individually ventilated
cages with spruce chips bedding, with a maximum of 5 mice per
cage. Male mice from different breeding pairs were never mixed to
avoid fighting of the mice. Water and food was available ad
libitum and was checked daily.
Plasmodium berghei ANKA 676m1cl1 (P. berghei ANKA), which
expresses a fusion protein of green fluorescent protein (GFP) and
firefly luciferase, was used to infect the mice. Sporozoites were
obtained by dissecting the salivary glands of P. berghei ANKA-
infected mosquitoes. The mosquitoes were kindly provided by Dr.
Robert Sauerwein (Nijmegen, The Netherlands). An equal
number of male and female mice at the age of 6 to 8 weeks
were infected with sporozoites, and mice were age matched
between WT and Ly49E KO mice. Mice were infected
intravenously (i.v.) with 10,000 sporozoites. 0.375 mg/ml 4-
aminobenzoic acid (PABA; Sigma-Aldrich, St. Louis, MO, USA)
was added to the drinking water twice a week to ensure optimal
parasite growth. All animal experimentation was performed after
approval of the Animal Ethical Committee at the Faculty of
Medicine and Health Sciences of Ghent University, Ghent,
Belgium (ECD 12/07).
Parasitemia, scoring of cerebral malaria and humane
endpoints
Liver parasitemia was visualized through whole body imaging
using the in vivo Imaging System (IVIS Lumina II; Perkin Elmer,
USA). Animals were anesthetized using isoflurane anesthesia, the
abdomen was shaved and D-luciferin dissolved in PBS (150 mg/kg
body weight; Caliper Life Sciences, USA) was injected intraper-
itoneally in the abdomen. Animals were kept anesthetized during
the measurements, which were performed within 10 minutes after
the injection of D-luciferin. Bioluminescence imaging was
acquired after an exposure time of 120 seconds. Luminescence
results are expressed as relative levels of luminescence. Blood
parasitemia was determined daily by flow cytometry. One drop of
blood (approximately 3 ml) was collected from the tail vein in an
EDTA-coated tube (MicrovetteH 500 K3E, Sarstedt, Essen,
Belgium) filled with 47 ml PBS. Samples were diluted 10-fold in
PBS and subsequently measured on a FACSCalibur (BD
Biosciences, San Jose, CA, USA) to determine the percentage of
GFP-positive, and thus P. berghei ANKA-infected, RBCs. Mice
were judged to develop cerebral malaria if they displayed
neurological signs such as loss of reflex, ataxia and paralysis. Mice
developed cerebral malaria between days 7 and 11 post-infection
(p.i.). In this period of time, animals were checked 3 times a day
and the mice were sacrificed by cervical dislocation as soon as the
indicated neurological signs were visible. Mice not affected by
cerebral malaria were sacrificed by cervical dislocation when
parasitemia reached 20–30%. We did not use analgesics because
animals were checked often enough to intervene when animals
were suffering.
Cell preparation
Spleen and liver lymphocytes were isolated from non-infected
and from P. berghei ANKA-infected WT and Ly49E KO mice that
were sacrificed by cervical dislocation at days 5 and 7 p.i. Spleens
were disrupted, minced and passed through a 40 mm cell strainer
(Falcon Franklin Lakes, NJ, USA). Erythrocytes were lysed with
ACK lysing buffer (Invitrogen Corporation, Carlsbad, CA, USA)
and cells were washed three times with DPBS. Liver peripheral
blood cells were removed by left ventricle perfusion with PBS.
After mechanical disruption of the liver, lymphocytes were isolated
using 37.5% Percoll (GE Healthcare, Barrington, IL, USA) density
centrifugation. Cells were washed with PBS and counted with
trypan blue to exclude dead cells. Cells were flow cytometrically
analyzed for cell membrane marker expression and for cytokine
production. For the latter, cells were incubated at 37uC and 5%
CO2 for 1 h in complete RPMI medium (this refers to RPMI1640
medium supplemented with 10% FCS, 100 U/ml penicillin,
100 mg/ml streptomycin, 2 mM glutamine and 50 mM 2-mercap-
toethanol (all from Invitrogen Corporation)) supplemented with
brefeldine A (1 mg/ml; Golgiplug, BD Biosciences). Cells were
collected, cell-surface stained and subsequently permeabilized
using Cytofix/Cytoperm reagent (BD Biosciences, San Jose, CA,
USA) and intracellularly stained with anti-IFNc and anti-TNFa
mAb.
Spleen and brain were isolated from non-infected and from P.
berghei ANKA-infected WT and Ly49E KO mice at the time of
paralysis. Spleen isolation occurred as described above. The brain
was isolated after left ventricle perfusion with PBS to remove
peripheral blood from the brain. The brain was mechanically
disrupted, minced and passed through a 70 mm filter. Brain
lymphocytes were isolated by using 40%/70% Percoll density
centrifugation. All cell suspensions were counted with trypan blue
to exclude dead cells and were flow cytometrically analyzed.
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Antibodies
Monoclonal antibodies used for labeling were anti-NK1.1
(phycoerythrin-cyanine-7-conjugated, clone PK136), anti-CD49b
(allophycocyanin (APC)-conjugated, clone DX5), anti-CD3 (pacific
blue-conjugated, clone 145-2C11), anti-CD69 (PE-conjugated,
clone H1.2F3), anti-cd-TCR (fluorescein (FITC)-conjugated, clone
GL3), anti-CD8a (APC-conjugated, clone Lyt-2), TNF-a (phyco-
erythrin (PE)-conjugated, clone MPG-XT22) and anti-IFN-c (PE-
conjugated, clone XMG1.2) (all from BDBiosciences, San Jose, CA,
USA). Anti-Ly49E/C (biotin-conjugated, clone 4D12) [19], anti-
Ly49E/F (FITC-conjugated, clone CM4, kindly provided by Dr.
C.G. Brooks, Newcastle upon Tyne, U.K.) [18], anti-Ly49H
(biotin-conjugated, clone 3D10, kindly provided by Dr. W.
Yokoyama, St. Louis, MO, USA) and anti-Ly49A (FITC-conjugat-
ed, clone JR9-318, kindly provided by Dr. J. Roland, Paris, France).
Anti-CXCR3 (PE-conjugated, clone 220803, R&D) and anti-CD4
(peridinin chlorophyll protein cyanine dye 5.5-conjugated, clone
L3T4, Biolegend). Biotinylated mAbs were detected by streptavidin
(APC-eFluorTM780-conjugated, eBiosciences).
Before staining, the FcR was blocked with anti-FccRII/III mAb
(unconjugated, clone 2.4G2, kindly provided by Dr. J. Unkeless,
New York, NY, USA). Live and dead cells were discriminated by
using propidium iodide or the LIVE/DEADH Fixable Aqua Dead
Cell Stain Kit (Invitrogen Corporation) for analysis of cell
membrane marker expression or cytokine production, respectively.
Samples were measured using a BD LSR II flow cytometer and
analyzed with FACSDiva 6.1.2 software (BD Biosciences).
Statistical analysis
Data were statistically evaluated using PASW statistics 21
software (SPSS Inc., Chicago, IL, USA). Datasets were analyzed
using the non-parametric 2-tailed Mann Whitney test or the Log-
rank Kaplan-Meier method. A p-value,0.05 was considered
statistically significant.
Results
Parasitemia of Plasmodium berghei-infected WT versus
Ly49E KO mice
Using P. berghei ANKA sporozoites, which expresses a fusion
protein of green fluorescent protein (GFP) and firefly luciferase, we
determined parasitemia both in liver and in blood and compared
WT to Ly49E KO mice. Based on a paper of Ploemen et al. [26] in
which it is shown that the highest parasite load in the liver is
observed at 44 h post-infection, we measured at this point in time
the luminescence of the liver region via whole body imaging. The
observed luminescence was 0.61610460.17 and 0.54610460.15
for WT and Ly49E KO, respectively. These values were not
significantly different (Figure 1A). In addition, we determined
blood parasitemia levels in WT and Ly49E KO mice by flow
cytometric analysis of the percentage of GFP-positive RBCs.
Parasitemia was detectable from day 5 p.i., after which only a
minor increase was observed until day 10 p.i. (Figure 1B).
Subsequently, parasitemia increased drastically and peaked at days
12 and 16 p.i., confirming the results of Hansen et al [27]. There
was a small, but significantly increased percentage of P. berghei
ANKA-infected RBCs in Ly49E KO as compared to WT mice at
days 6 (0.49%60.042 vs 0.40%60.041) and 7 p.i. (1.20%60.072
vs 1.07%60.074). However, as these differences are very small, it
can be questioned whether they are functionally relevant. This
difference was also no longer observed from day 8 p.i., with the
exception of day 16 p.i. where again a higher parasitemia was
observed in Ly49E KO mice (27.75%61.89 vs WT:
22.57%61.85).
Phenotypical and functional analysis of liver and spleen
lymphocytes of WT versus Ly49E KO mice at the early
phase of P. berghei ANKA infection
Roland et al. [4] showed that at days 5 and 7 p.i. the liver NK
cell number increases, while the spleen NK cell number decreases.
As Takeda et al. [28] have shown that liver NK cells can be
subdivided on the basis of DX5 expression, and as we have shown
that Ly49E is preferentially expressed by DX52 liver NK cells
[25], we compared the absolute number of DX52 and DX5+ liver
NK cells in P. berghei ANKA-infected WT vs Ly49E KO mice at
days 5 and 7 p.i. (Figure 2A). As also liver T and NKT cells are
involved in the immune response towards P. berghei ANKA
infection [29;30], these were analyzed in parallel. As expected, we
observed an increase in the liver NK cell number at day 5 p.i. and,
more pronounced, at day 7 p.i. The strong increase of the liver
NK cell number at day 7 p.i. was mainly due to an increase of the
DX5+ subpopulation. There was no significant difference between
Figure 1. WT and Ly49E KOmice display a similar course of parasitemia. Mice were infected i.v. with 10,000 P. berghei ANKA sporozoites. (A)
Liver parasitemia was determined at 44 h post-infection via luminescence imaging. Luminescence results are expressed as relative levels of
luminescence. Each data point represents one individual mice; the horizontal bar represents the mean. The observed luminescence was
0.61610460.17 and 0.54610460.15 for WT and Ly49E KO, respectively (n = 10). These values were not significantly different using the 2-tailed Mann
Whitney test. (B) Blood parasitemia was monitored daily by flow cytometric analysis of peripheral blood. The data presented were obtained by
combined analysis of five experiments (WT, started with 89 mice and ended with 18; KO, started with 84 mice and ended with 16) and are shown as
mean 6 SEM. Statistical analysis was performed using the 2-tailed Mann Whitney test. * indicates a significant difference with p,0.05.
doi:10.1371/journal.pone.0087463.g001
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Figure 2. Role of Ly49E expression in lymphocyte phenotype and cytokine production in early P. berghei ANKA infection. Liver
lymphocytes (A–C) and spleen cells (D–E) were isolated from non-infected, or from 5 d and 7 d P. berghei ANKA-infected WT and Ly49E KO mice, as
indicated in the figure. Freshly isolated liver lymphocytes (A) and spleen cells (D) were analyzed for their subpopulation composition by gating on NK
cells (liver: CD32NK1.1+DX52 and CD32NK1.1+DX5+; spleen: CD32NK1.1+), NKT cells (CD3dimNK1.1+) and T cells (CD3+NK1.12). The absolute cell
number was calculated based on the total viable cell number obtained after isolation and the representative percentages of each cell population.
CD69, IFN-c and TNF-a expression by liver (B) and spleen (E) NK, NKT and T cells was determined. (A,B,D,E) Data are represented as mean 6 SEM
(n = 5). Statistical analysis was performed using the 2-tailed Mann Whitney test. * indicates a significant difference with p,0.05 and ** a significant
difference with p,0.01. (C) Overlay histograms show unstained, and CD69-, IFN-c- and TNF-a-stained DX52 liver NK cells from non-infected and day 5
P. berghei ANKA-infected WT and Ly49E KO mice, as indicated. The histograms of one representative mouse of each group is shown. The mean6 SEM
of 5 different mice is shown for P. berghei ANKA-infected (above the gate bar) and for non-infected mice (below the gate bar).
doi:10.1371/journal.pone.0087463.g002
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WT and Ly49E KO mice. Whereas no change in the liver NKT
cell number was observed, there was a strong increase in the liver
T cell number at day 7 p.i., which was similar for WT vs Ly49E
KO mice (Figure 2A). In the spleen, we observed a decrease in the
NK cell number in P. berghei ANKA-infected mice, confirming the
results of Roland et al. [4], and which was comparable in WT vs
Ly49E KO. No significant difference in spleen NKT and T cell
numbers was observed between WT and Ly49E KO mice
(Figure 2D).
Next we investigated the activation status of hepatic and splenic
lymphocytes. Expression of the early activation marker CD69 was
clearly increased on both DX52 and DX5+ liver NK cells, spleen
NK cells and liver and spleen T cells of P. berghei ANKA-infected
mice at days 5 and 7 p.i. (Figure 2B;E). IFN-c production was
highly induced in both DX52 and DX5+ liver NK cells, spleen
NK cells, and in liver and spleen NKT and T cells of P. berghei
ANKA-infected mice. TNF-a was mainly produced by liver NK
cells. The comparison of WT and Ly49E KO mice shows lower
expression of CD69, IFN-c and TNF-a in DX52 liver NK cells of
Ly49E KO mice at day 5 p.i. (Figure 2B–C). For splenic T cells,
there was a significant decrease in IFN-c and TNF-a production
in infected Ly49E KO mice compared to WT mice at day 7 p.i.
(Figure 2E).
In WT mice, Ly49E expression was clearly upregulated upon
infection in liver DX52 NK cells and NKT cells at day 5 p.i., and
remained high at day 7 p.i. (Figure 3). In addition to Ly49E, NK
and NKT cells also express other members of the Ly49 family, of
which we analyzed the inhibitory Ly49A, Ly49C and Ly49F and
the activating Ly49H receptors. Compared to WT mice, a
significantly higher percentage of Ly49E KO DX52 and DX5+
liver NK cells expressed Ly49F, whereas a significantly lower
percentage of Ly49E KO DX5+ liver NK cells expressed Ly49H
at day 7 p.i. There was no significant difference in expression of
other NK receptors on spleen NK, NKT and T cells from WT vs
Ly49E KO mice upon P. berghei ANKA infection (Figure 3).
Development of cerebral malaria in WT versus Ly49E KO
mice
Upon i.v. infection with 10,000 P. berghei ANKA sporozoites of
both WT and Ly49E KO mice, mice were monitored daily and
evaluated for neurological signs such as loss of reflex, ataxia and
Figure 3. NK receptor expression on NK and NKT cells in early P. berghei ANKA infection. NK cell receptor expression is shown for the
indicated gated lymphocyte subpopulations of liver and spleen. The expression of Ly49E was determined by gating on Ly49E/C (mAb 4D12) and
Ly49E/F (mAb CM4) double-positive cells. Data are represented as mean percentage 6 SEM (n= 5). Statistical analysis was performed using the 2-
tailed Mann Whitney test. * indicates a significant difference with p,0.05 and ** a significant difference with p,0.01.
doi:10.1371/journal.pone.0087463.g003
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paralysis, reflecting the development of cerebral malaria. Devel-
opment of cerebral malaria was studied in five separate
experiments. The percentage of animals developing cerebral
malaria in each individual experiment is shown in Figure 4A, and
the kinetics of cerebral malaria development of the 5 pooled
experiments, consisting of 86 WT and 80 Ly49E KO mice, are
presented in Figure 4B. The first animals developing cerebral
malaria were observed at day 7 and day 8 p.i. in WT and Ly49E
KO mice, respectively, whereas the last animals that developed
cerebral malaria were observed at day 10 p.i. in both groups of
mice (Figure 4B). No significant difference was observed in the
kinetics and the percentage of cerebral malaria development in
WT vs Ly49E KO mice (p = 0.325, Kaplan-Meier Log-rank
method). The observed incidence of cerebral malaria upon
infection with sporozoites was around 30%, whereas others [31–
34] have reported an incidence of cerebral malaria of approx-
imately 90% upon injection of infected RBCs. We also tested this
in the Ly49E KO and WT mice and observed an incidence of
cerebral malaria of 80–90%, with no difference between WT and
Ly49E KO mice (data not shown).
Phenotypical and functional analysis of spleen and brain
lymphocytes of mice with cerebral malaria
It has been shown that mice that develop cerebral malaria have
a decrease in splenic NK cells, and an increase in brain NK cells
[7]. Also CD4+ and in particular CD8+ T cells migrate to the
brain. The chemokine receptor CXCR3, which is crucial for this
migration, is upregulated on ab-T cells in an NK cell-dependent
manner [7]. In our study, we analyzed by flow cytometry spleen
and brain lymphocytes from WT and Ly49E KO mice at the day
of paralysis, and compared them to non-infected mice. In
agreement to Hansen et al. [7], we showed that during cerebral
malaria splenic NK cells decreased, while the percentage of brain
NK cells increased (Figure 5A+D). Also cd T, CD4+ T and, more
pronounced, CD8+ T cells were significantly increased in the brain
of mice that developed cerebral malaria compared to non-infected
mice (Figure 5D). Significantly less CD8+ T cells accumulated in
the brain of Ly49E KO mice with cerebral malaria compared to
affected WT mice (Figure 5D).
As CXCR3 is a crucial chemokine receptor in the migration of
T cells to the brain during cerebral malaria, we studied its
expression in spleen and brain lymphocytes. CXCR3 expression
was increased on spleen and brain CD4+ T cells in cerebral
malaria mice compared to non-infected mice (Figure 5B;E). There
were no significant differences between WT and Ly49E KO mice.
We also analyzed CD69 expression. As expected, CD69 expres-
sion was increased on spleen and brain NK and T cell
subpopulations. No significant difference was observed between
WT and Ly49E KO mice (Figure 5B;E). Finally, NK receptor
expression analysis on NK and NKT cells shows that there were
no differences in cerebral malaria vs non-infected mice
(Figure 5C;F).
Discussion
This study shows that deficiency in Ly49E expression results in
lower parasitemia at the early stage of P. berghei ANKA infection,
i.e. at days 6–7 p.i., which correlates with lower IFN-c and TNF-a
expression in liver NK cells. These differences are, however, lost
thereafter. Also cerebral malaria develops similarly in WT vs
Ly49E KO mice. Collectively, we show that Ly49E, which is a
regulatory NK receptor expressed on liver NK and NKT cells,
only has a temporarily role in the host immune response against P.
berghei ANKA infection.
It has been shown that liver NK cells are involved in the early
immune response controlling Plasmodium infection. Comparison of
the outcome of Plasmodium infection in RAG22/2 mice, which
have normal NK cell numbers but lack T and B cells, and
RAG22/2 cc2/2 mice, which lack T, B and NK cells, showed
that NK cells act on the pre-erythrocytic phase of parasite
development in vivo as RAG22/2 cc2/2 mice are more sensitive to
sporozoite infection than RAG22/2 mice, whereas survival rates
are similar for the two strains following infection with parasitized
Figure 4. Cerebral malaria development in P. berghei ANKA-infected WT vs Ly49E KO mice. P. berghei ANKA-infected WT and Ly49E KO
mice were monitored daily for cerebral malaria development. (A) The incidence of cerebral malaria development in 5 separate experiments. The
results are presented as (number of animals with cerebral malaria)/(total number of animals studied). The last line represents the total number of
mice affected with cerebral malaria during these 5 experiments. (B) The cumulative incidence and kinetics of cerebral malaria development in the 5
pooled experiments (WT, n = 86; Ly49E KO, n = 80). Cerebral malaria development results were analyzed by Log-rank (Kaplan-Meier). There was no
significant difference in WT vs Ly49E KO mice.
doi:10.1371/journal.pone.0087463.g004
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RBCs [4]. The role of NK cells in the later stage of infection, and
in cerebral development in particular, has been previously
evaluated with somewhat contradictory results. Hansen et al. [7]
showed that depletion of NK cells by anti-asialo GM1 antibody
protects animals against P. berghei ANKA-mediated cerebral
malaria, while parasitemia is increased in these animals. On the
contrary, Yanez et al. [32] reported that depletion of NK cells with
anti-NK1.1 antibody fails to protect mice from P. berghei ANKA-
mediated cerebral malaria. However, usage of anti-NK1.1
antibody results in crosslinking of the NK1.1 receptor and in
IFN-c production [35]. Whereas IFN-c is protective in the early
phase of infection [6;36;37], it provokes enhancing effects on
cerebral malaria development [31]. Also NKT cells, which
coexpress NK receptors and T cell receptors, have been implicated
in the regulation of cerebral malaria. CD12/2 or Ja2812/2
C57BL/6 mice, which lack CD1-restricted and Va14 NKT cells,
respectively, are partially protected from cerebral malaria devel-
opment upon injection of P. berghei ANKA-parasitized RBC. This
correlates with decreased IFNc production as compared to WT
mice [38].
All these data indicate a substantial role for NK and NKT cells
in the control of P. berghei ANKA infection, either directly via
secretion of pro-inflammatory effector cytokines or indirectly by
inducing TH1 polarization. The activity of NK cells, and also
partially of NKT cells, is regulated by NK receptors, which can
either be activating or inhibitory. In mice, NK receptors are
encoded by a genetic locus, i.e. the NK complex, which is located
on chromosome 6. Among other genes, the NK complex is
comprised of the Cd94 gene and of the multigene families Nkg2 and
Ly49. The balance between the signaling of activating and
inhibitory CD94/NKG2 and Ly49 receptors determines whether
NK cell activation will occur. Ly49E is a unique member of the
Figure 5. Analysis of spleen and brain lymphocytes of cerebral malaria developing P. berghei ANKA-infected WT vs Ly49E KO mice.
Freshly isolated spleen (A–C) or brain (D–F) NK (CD32NK1.1+), NKT (CD3dimNK1.1+), CD4+ T (CD3+CD4+), CD8+ T (CD3+CD8+) and cd T cells
(CD3+TCRcd+) from non-infected WT and Ly49E KO mice or cerebral malaria developing P. berghei ANKA-infected WT and Ly49E KO mice (as indicated
in the figure) were analyzed by flow cytometry. The percentage of these lymphocyte populations are shown in A and D. CXCR3 and CD69 expression
was analyzed within each lymphocyte population (B and E). NK receptor expression was determined in NK and NKT cells (C and F). Data represent the
results of 2 independent experiments (WT, n = 8; KO, n = 11) and are shown as mean 6 SEM. Statistical analysis was performed using the 2-tailed
Mann Whitney test. * represent a significant difference with p,0.05.
doi:10.1371/journal.pone.0087463.g005
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Ly49 receptor family, with several distinctive characteristics.
Unlike other Ly49 receptors, Ly49E does not bind classical
MHC class-I ligands [16]. Instead, Ly49E is triggered through
interaction with the non-MHC class-I molecule uPA [17]. Another
unique characteristic is that DX52 liver NK cells express high
levels of Ly49E, whereas other Ly49 members are virtually absent
[25]. Collectively, these characteristics pointed towards a possible
regulatory role for Ly49E in malaria pathogenesis. Also supporting
this hypothesis was that uPA contributes to the mortality in P.
berghei ANKA infected mice. Piguet et al. [33] argues that this is due
to increased platelet trapping and thus thrombocytopenia. We
hypothesized an additional explanation as uPA, which we showed
to trigger the Ly49E receptor [17], thus also exerts its effects by
regulation of Ly49E-expressing immune cells.
Whereas Ly49E is highly expressed on DX52 liver NK cells, its
expression on NK cells in peripheral blood, spleen and lymph
nodes is very low in adult mice [18;19;25]. However, Ly49E
expression can be induced on spleen NK cells from adult mice
after in vitro culture in the presence of IL-2 or IL-15 [39]. Given
this differential expression of Ly49E in liver versus other
peripheral NK cells, we expected to observe Ly49E-mediated
immune effects mainly during the early stage of Plasmodium
infection, which starts with the liver stage. We therefore injected
the mice with P. berghei ANKA sporozoites instead of P. berghei
ANKA-parasized RBCs, as injected sporozoites start the infection
with the liver stage, whereas with parasized RBCs the liver stage is
skipped and infection directly starts from the blood stage. As
expected [4;7], we observed an increase in the liver NK cell
number at day 5 p.i. and, more pronounced, at day 7 p.i. There
was also a strong increase in the liver T cell number at day 7 p.i.
This increase in liver NK and T cell numbers was comparable in
WT vs Ly49E KO mice. Importantly, in WT mice, Ly49E
expression was clearly upregulated in liver DX52 NK cells and
NKT cells at day 5 p.i., and remained high at day 7 p.i. We
observed significantly increased parasitemia in Ly49E KO as
compared to WT mice at days 6 and 7 p.i. This correlated with
lower expression of the protective cytokines IFN-c and TNF-a in
DX52 liver NK cells of Ly49E KO mice at day 5 p.i. However,
these differences were not observed in the later stage of infection.
Also cerebral pathology, in which leukocyte and platelet seques-
tration in the brain blood vessels occurs and for which a causal role
has been demonstrated for the cytokine IFNc [31] and for NK,
NKT and T cells [7;32;38], developed with similar kinetics and
incidence in WT vs Ly49E KO mice. Cumulatively, our findings
point towards a regulating role for the Ly49E receptor in the early
host response towards P. berghei ANKA sporozoite infection but,
although significant, it is a relatively minor effect which fades
during the later stage of infection.
P. berghei ANKA infection results in cerebral malaria depending
on the genetic background of the mice as C57BL/6 mice are
highly susceptible, while BALB/c mice are resistant. In a very
elegant study, Hansen et al. [27] have shown that the NK receptor
complex determines susceptibility to P. berghei ANKA-mediated
cerebral malaria as congenic BALB.B6-Cmv1r mice, in which the
NK complex from C57BL/6 mice has been introduced in the
BALB/c background, have an increased rate of cerebral malaria
development as compared to resistant BALB/c mice. The NK
complex regulates murine cerebral malaria by a mechanism
independent of parasite growth rates, as parasitemia levels are
unchanged. The NK complex spans a region of approximately 4.7
mB in which several genes are present, including the multigene
families Nkg2 and Ly49. Although Ly49E is a member of the Ly49
family, it was unlikely that Ly49E is responsible for the observed
increased cerebral malaria incidence in congenic BALB.B6-Cmv1r
mice as, in contrast to the extensive allelic polymorphism of other
Ly49 genes, Ly49e is highly conserved between mouse strains, and
also has an identical sequence in C57BL/6 and BALB/c mice
[40]. In our study, in which the C57BL/6 background was used,
Ly49E KO mice developed cerebral malaria to the same extent
and with similar kinetics as WT mice. This shows that another
gene, or a set of genes, in the NK complex is responsible for the
cerebral malaria susceptibility.
In conclusion, although there are several indications that the
Ly49E receptor could play a crucial regulatory role in the host
immune response towards P. berghei ANKA infection, we show that
Ly49E-deficient mice only display a temporarily increased
parasitemia, which correlates with decreased activation of liver
NK cells and cytokine production. The subsequent stage of
infection, including cerebral malaria development, is not affected.
From these data we conclude that Ly49E expression only has a
temporarily role in the immune control of Plasmodium pathogen-
esis.
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